Sernova Biotherapeutics (SVA.TO) Q1 2025 Earnings

14MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.04
-0.03
-0.02
-0.01

Details

Expected EPS
-0.018955502
Actual EPS
-0.012075102
Surprise EPS
0.01
Surprise Percent
+36.3%

Description

Sernova Biotherapeutics (SVA.TO) has reported earnings of -0.012075102 per share for Q1 2025.

0 Comments

Share your thoughts